Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany
2018 ◽
Vol 268
◽
pp. 99-107
◽
2017 ◽
Vol 69
(11)
◽
pp. 1712
2011 ◽
Vol 12
(10)
◽
pp. 1481-1489
◽
2014 ◽
Vol 21
(10)
◽
pp. 1044-1054
◽
2018 ◽
Vol Volume 13
◽
pp. 9-19
◽
2003 ◽
Vol 92
(1)
◽
pp. 79-81
◽
2008 ◽
Vol 9
(5)
◽
pp. 669-676
◽
2010 ◽
Vol 17
(2)
◽
pp. 167-175
◽
2004 ◽
Vol 93
(4)
◽
pp. 525
◽